| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |